AC Immune (ACIU) Cash & Equivalents (QoQ) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | AC Immune | 325.88 Mn | 211.53 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.33% |
| Sep 30, 2025 | -20.85% |
| Jun 30, 2025 | 97.37% |
| Mar 31, 2025 | -46.39% |
| Dec 31, 2024 | 10.67% |
| Sep 30, 2024 | -56.89% |
| Jun 30, 2024 | 32.89% |
| Mar 31, 2024 | -26.19% |
| Dec 31, 2023 | 144.81% |
| Sep 30, 2023 | 2.90% |
| Jun 30, 2023 | -43.43% |
| Mar 31, 2023 | 89.39% |
| Dec 31, 2022 | -28.85% |
| Sep 30, 2022 | -46.02% |
| Jun 30, 2022 | 36.31% |
| Mar 31, 2022 | -29.76% |
| Dec 31, 2021 | 87,379.39% |
| Sep 30, 2021 | -10.75% |
| Jun 30, 2021 | -31.66% |
| Mar 31, 2021 | -99.91% |
| Dec 31, 2020 | -7.22% |
| Sep 30, 2020 | 4.15% |
| Jun 30, 2020 | -2.58% |
| Mar 31, 2020 | -3.35% |
| Dec 31, 2019 | -9.29% |
| Sep 30, 2019 | -99.89% |
| Jun 30, 2019 | 91,892.80% |
| Mar 31, 2019 | 41.87% |
| Dec 31, 2017 | -20.30% |
| Sep 30, 2017 | 2.39% |
| Jun 30, 2017 | 12.33% |
| Mar 31, 2017 | -9.65% |
| Dec 31, 2016 | -2.44% |
| Sep 30, 2016 | -0.54% |